Concepedia

Michał Mielcarek

MM

Statistics

Publications

23

Citations

1.1K

H-Index

18

Active since

2000

Affiliations

Imperial College London(Current)

King's College London

Poznan University of Medical Sciences

Gdańsk Medical University

CHDI Foundation

Michał Mielcarek is an author at Imperial College London specializing in medicine, physiology, and cell biology.

ORCID

Top concepts

Publications per year

2000–2022

23

Publications

23

HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration

Michał Mielcarek, Christian Landles, Andreas Weiss et al. · PLoS Biology · 2013 · 166 citations · Full text

SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease

Michał Mielcarek, Caroline Benn, Sophie Franklin et al. · PLoS ONE · 2011 · 159 citations · Full text

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease

Michał Mielcarek, Linda Inuabasi, Marie K. Bondulich et al. · PLoS Genetics · 2014 · 91 citations · Full text

, , +16

Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model

Michał Mielcarek, Ryszard T. Smoleński, Mark Isalan · Frontiers in Physiology · 2017 · 69 citations · Full text

Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease

Caroline Benn, Rachel Butler, Lydia Mariner et al. · PLoS ONE · 2009 · 65 citations · Full text

, , +21

1–5 of 23